Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
29
|
pubmed:dateCreated |
1992-11-18
|
pubmed:abstractText |
Interferon-gamma (IFN-gamma) has been shown to inhibit human immunodeficiency virus (HIV) replication in macrophages. However, the site of its effect on the HIV infectious cycle is unknown. We show here that IFN-gamma inhibits the transactivation of HIV long terminal repeat (LTR) during viral infection and that it antagonizes tat effect in HT4LacZ-1 cells. HT4LacZ-1 is an indicator CD4+ HeLa cell line for HIV infectivity, because it harbors a HIV LTR-LacZ gene susceptible to transactivation by tat. It was used in combination with a computer-assisted image analyzer to quantify: (i) the number of transactivated foci following HIV infection, (ii) their individual level of transactivation, and (iii) the fusion potency of infected cells. IFN-gamma induced a 75% decrease of the number of transactivated foci following infection of HT4LacZ-1 cells by HIV. The remaining 25% foci still susceptible to transactivation were transactivated at a lower level than in control cultures, and the fusion potency of infected cells was strongly decreased. IFN-gamma acted after HIV entry into the cell and independently of reverse transcription. IFN-gamma antagonized tat-induced LTR transactivation: it inhibited transactivation of HT4LacZ-1 cells when tat was provided either from a SV40-based expression vector of tat or by polyethylene glycol-induced cell fusion with HeLa-tat-III cells. These results suggest that IFN-gamma affects the expression or the activity of cellular factors interacting with tat and that the high level of IFN-gamma production associated with HIV infection plays a role in the establishment of HIV latency.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0021-9258
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
267
|
pubmed:geneSymbol |
lacZ,
tat
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
20565-70
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:1400376-Genes, tat,
pubmed-meshheading:1400376-Giant Cells,
pubmed-meshheading:1400376-HIV Long Terminal Repeat,
pubmed-meshheading:1400376-HIV-1,
pubmed-meshheading:1400376-HeLa Cells,
pubmed-meshheading:1400376-Humans,
pubmed-meshheading:1400376-Interferon-gamma,
pubmed-meshheading:1400376-Kinetics,
pubmed-meshheading:1400376-Transcriptional Activation,
pubmed-meshheading:1400376-Transfection,
pubmed-meshheading:1400376-Virus Replication,
pubmed-meshheading:1400376-Zidovudine,
pubmed-meshheading:1400376-beta-Galactosidase
|
pubmed:year |
1992
|
pubmed:articleTitle |
Antagonistic effect of interferon-gamma on tat-induced transactivation of HIV long terminal repeat.
|
pubmed:affiliation |
Institut National de la Santé et de la Recherche Médicale, Clamart, France.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|